EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study

Depressive Symptome sind mit schlechter Prognose und niedrigerer pathologischer Komplettremission bei triple-negativem Brustkrebs verbunden: eine einzentrumige retrospektive Studie

Hailin Yang, Xuanyi Wang, Kunxia Chen, Xiaolu Hu, Hanzhi Li, Lingfeng Tang, Shengchun Liu

Frontiers in Oncology · 11.11.2026 · 16

DOI: 10.3389/fonc.2026.1996522 ↗

Auf einen Blick

Bei 4.060 Patient:innen mit triple-negativem Brustkrebs waren moderate/schwere depressive Symptome mit schlechterem Überleben und niedrigerer pCR verbunden. Die NHANES-Analyse zeigte nur einen Zusammenhang mit Selbstangabe einer Krebserkrankung.

Fragestellung

Sind depressive Symptome bei triple-negativem Brustkrebs mit Überleben und Ansprechen auf neoadjuvante Chemotherapie assoziiert?

Methode

Einzentrumige retrospektive Studie mit 4.060 TNBC-Patient:innen; PHQ-9 zu Baseline; Cox- und logistische Regressionen. Zusätzliche explorative Querschnittsanalyse in NHANES 2009–2018.

Ergebnisse

Bei 3.878 Patient:innen ohne Basismetastasen waren moderate/schwere Symptome mit höherem Risiko für OS (HR 1,626; 95 %-KI 1,301–2,033) und DFS (HR 1,439; 95 %-KI 1,170–1,770) verbunden. pCR: 26,34 % vs. 36,18 %; OR 0,668 (95 %-KI 0,474–0,930).

Einschränkungen

Retrospektiv; mögliche Reverse Causation; unberücksichtigte Behandlungsgabe; keine kausale Aussage.

Schlussfolgerung der Autor:innen

Moderate/schwere depressive Symptome zu Baseline waren in dieser retrospektiven TNBC-Kohorte mit schlechterem Überleben und niedrigerer pCR verbunden.

Kernaussagen

  • OS: HR 1,626; 95 %-KI 1,301–2,033
  • pCR: 26,34 % vs. 36,18 %; OR 0,668
  • NHANES: Zusammenhang mit Selbstangabe von Krebs, Brustkrebs nicht signifikant

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 11.11.2026. Verfasst von Hailin Yang und 6 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Depressive symptoms are common in patients with cancer, but their associations with survival and treatment response in triple-negative breast cancer (TNBC) remain uncertain.

Methods

This single-center retrospective study screened 19,335 patients with breast cancer treated during 2015–2025 and included 4,060 patients with TNBC. A single baseline Patient Health Questionnaire-9 (PHQ-9) assessment classified patients into normal/mild (score <10; n = 3,666) and moderate/severe (score ≥10; n = 394) symptom groups. Survival analyses included 3,878 patients without baseline distant metastasis; pathological complete response (pCR) analyses included 1,689 neoadjuvant chemotherapy (NACT) recipients with available response data. Cox and logistic regression models adjusted for recorded clinicopathological variables. An exploratory cross-sectional analysis of NHANES 2009–2018 was conducted separately.

Results

In the TNBC cohort, moderate/severe baseline depressive symptoms were associated with differences in T-stage and Ki-67 distributions and a higher frequency of baseline distant metastasis. N-stage distributions did not differ significantly (P = 0.059). Among patients without baseline distant metastasis, adjusted hazard ratios were 1.626 for overall survival (OS; 95% CI: 1.301–2.033; P < 0.001) and 1.439 for disease-free survival (DFS; 95% CI: 1.170–1.770; P < 0.001). The pCR rate was 26.34% in the moderate/severe group versus 36.18% in the normal/mild group (adjusted OR = 0.668; 95% CI: 0.474–0.930; P = 0.018). In NHANES, depressive symptoms were associated with higher odds of a self-reported history of any cancer (OR = 1.41; 95% CI: 1.19–1.67), whereas the breast cancer estimate was not statistically significant (OR = 1.43; 95% CI: 0.97–2.05).

Conclusion

Moderate/severe baseline depressive symptoms were associated with worse survival and lower pCR in this retrospective TNBC cohort. Reverse causation and unaccounted-for treatment delivery limit interpretation. These findings do not establish a causal effect or the prognostic utility of PHQ-9 beyond established factors. Prospective studies with repeated symptom assessments and detailed treatment records are needed.

Zitieren

APA

Yang, H., Wang, X., Chen, K., Hu, X., Li, H., Tang, L., & Liu, S. (2026). Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1996522

Vancouver

Yang H, Wang X, Chen K, Hu X, Li H, Tang L, et al. Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1996522

BibTeX
@article{Yang2026,
  author = {Yang, Hailin and Wang, Xuanyi and Chen, Kunxia and Hu, Xiaolu and Li, Hanzhi and Tang, Lingfeng and Liu, Shengchun},
  title = {Depressive symptoms are associated with poor prognosis and lower pathological complete response in triple-negative breast cancer: a single-center retrospective study},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1996522}
}
Kostenlos starten →